Neil F. McFarlane
2020
In 2020, Neil F. McFarlane earned a total compensation of $1.7M as Chief Executive Officer at Adamas Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $31,300 |
|---|---|
| Non-Equity Incentive Plan | $431,300 |
| Option Awards | $233,220 |
| Salary | $604,167 |
| Stock Awards | $199,000 |
| Other | $193,954 |
| Total | $1,692,941 |
McFarlane received $604.2K in salary, accounting for 36% of the total pay in 2020.
McFarlane also received $31.3K in bonus, $431.3K in non-equity incentive plan, $233.2K in option awards, $199K in stock awards and $194K in other compensation.
Rankings
In 2020, Neil F. McFarlane's compensation ranked 6,301st out of 13,090 executives tracked by ExecPay. In other words, McFarlane earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,301 out of 13,090 | 52nd |
Division Manufacturing | 2,598 out of 5,621 | 54th |
Major group Chemicals And Allied Products | 1,045 out of 2,254 | 54th |
Industry group Drugs | 903 out of 1,954 | 54th |
Industry Pharmaceutical Preparations | 675 out of 1,459 | 54th |
Source: SEC filing on April 19, 2021.
McFarlane's colleagues
We found two more compensation records of executives who worked with Neil F. McFarlane at Adamas Pharmaceuticals in 2020.